Cargando…

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma

Accumulating evidence has implicated members of the procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) gene family, PLOD1, PLOD2, and PLOD3, in cancer progression and metastasis. However, their expression, prognostic value, and mechanisms underlying their roles in lung adenocarcinoma (LUAD) hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Yiming, Sun, Jing, Zhang, Guirong, Yu, Tao, Piao, Haozhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899219/ https://www.ncbi.nlm.nih.gov/pubmed/35265665 http://dx.doi.org/10.3389/fmolb.2021.770729

Ejemplares similares

Analysis of the Prognostic Value and Gene Expression Mechanism of SHOX2 in Lung Adenocarcinoma
por: Li, Nanhong, et al.
Publicado: (2021)

Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma
por: Cao, Congcong, et al.
Publicado: (2021)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Expression and Prognostic Value of MCM Family Genes in Osteosarcoma
por: Zhou, Jian, et al.
Publicado: (2021)

Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker
por: Sui, Yutong, et al.
Publicado: (2021)

A Fe(2+)-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes
por: Scietti, Luigi, et al.
Publicado: (2022)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
por: Li, Yanqi, et al.
Publicado: (2021)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021)

Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer
por: Lu, Yi, et al.
Publicado: (2021)

Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity
por: Zheng, Pengdou, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic Implications and Immune Infiltration Characteristics of Chromosomal Instability-Related Dysregulated CeRNA in Lung Adenocarcinoma
por: Guo, Shengnan, et al.
Publicado: (2022)

Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma
por: Lin, Guofu, et al.
Publicado: (2021)

Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Yi, Kezhen, et al.
Publicado: (2021)

Identification of TRP-Related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Lung Adenocarcinoma
por: Sun, Sibo, et al.
Publicado: (2022)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
por: Zhao, Yang, et al.
Publicado: (2022)

Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer
por: Gan, Junqing, et al.
Publicado: (2020)

The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
por: Wang, Guanghui, et al.
Publicado: (2022)

The Prognostic Value and Mechanisms of TMEM16A in Human Cancer
por: Chen, Wenjian, et al.
Publicado: (2021)

Corrigendum: Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-Small-Cell Lung Cancer
por: Gan, Junqing, et al.
Publicado: (2021)

Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma
por: Fan, Dengxia, et al.
Publicado: (2023)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
por: Xiao, Junbo, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
por: Nai, Aitao, et al.
Publicado: (2022)

TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma
por: Xiao, Xinhua, et al.
Publicado: (2022)

Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Jiang, Xiulin, et al.
Publicado: (2022)

Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction
por: Zhou, Chengmao, et al.
Publicado: (2020)

Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach
por: Wang, Junhao, et al.
Publicado: (2021)

Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma
por: Li, Changjiu, et al.
Publicado: (2021)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
por: Lin, Xinqing, et al.
Publicado: (2020)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes
por: Huang, Xin, et al.
Publicado: (2023)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sdjndit8083beoq5dng0et51ql